SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Sugg S, Donegan W. Staging and prognosis. In: DoneganW, SprattJ, editors. Cancer of the breast, 5th ed. Philadelphia: Saunders, 2002: 477506.
  • 2
    SobinLH, WittekindC, editors. TNM classification of malignant tumors, 6th ed. New York: John Wiley & Sons, 2002.
  • 3
    GreeneFL, PageDL, FlemingID, et al., editors. AJCC cancer staging manual, 6th ed. New York: Springer-Verlag, 2002.
  • 4
    Guth U, Moch H, Herberich L, Holzgreve W. Noninflammatory breast carcinoma with skin involvement. Cancer. 2004; 100: 470478.
  • 5
    Shen J, Valero V, Buchholz TA, et al. Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy. Ann Surg Oncol. 2004; 11: 854860.
  • 6
    Brito RA, Valero V, Buzdar AU, et al. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M. D. Anderson Cancer Center experience. J Clin Oncol. 2001; 19: 628633.
  • 7
    Low JA, Berman AW, Steinberg SM, Danforth DN, Lippman ME, Swain SM. Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy. J Clin Oncol. 2004; 22: 40674074.
  • 8
    Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989; 63: 181187.
  • 9
    Chang J, Hilsenbeck S. Prognostic and predictive markers. In: HarrisJ, LippmanM, MorrowM, OsborneK, editors. Diseases of the breast, 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2004: 675696.
  • 10
    WittekindC, GreeneFL, HensonDE, HutterRVP, SobinLH, editors. TNM supplement. A commentary on uniform use, 3rd ed. New York: Wiley-Liss, 2004.
  • 11
    El-Tamer M, Hussain S, Weedon J, et al. Prognoses of T4 breast cancer subsets. Ann Surg Oncol. 2002; 9: 340345.
  • 12
    Poole GV, Thigpen JT, Vance RB, Barber WH. Management of women who present with T4 breast cancer. Am Surg. 2004; 70: 662666; discussion, 666–667.
  • 13
    Price A, Kerr GR, Rodger A. Primary radiotherapy for T4 breast cancer. Clin Oncol (R Coll Radiol). 1992; 4: 217221.
  • 14
    Rao DV, Bedwinek J, Perez C, Lee J, Fineberg B. Prognostic indicators in Stage III and localized Stage IV breast cancer. Cancer. 1982; 50: 20372043.
  • 15
    Rubens RD, Armitage P, Winter PJ, Tong D, Hayward JL. Prognosis in inoperable Stage III carcinoma of the breast. Eur J Cancer. 1977; 13: 805811.
  • 16
    Sutherland CM, Mather FJ. Long-term survival and prognostic factors in patients with regional breast cancer (skin, muscle, and/or chest wall attachment). Cancer. 1985; 55: 13891397.
  • 17
    Valagussa P, Zambetti M, Bonadonna G, Zucali R, Mezzanotte G, Veronesi U. Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapy. Breast Cancer Res Treat. 1990; 15: 137147.
  • 18
    Wieland AW, Louwman MW, Voogd AC, van Beek MW, Vreugdenhil G, Roumen RM. Determinants of prognosis in breast cancer patients with tumor involvement of the skin (pT4b). Breast J. 2004; 10: 123128.
  • 19
    Yildirim E, Semerci E, Berberoglu U. The analysis of prognostic factors in Stage III-B non-inflammatory breast cancer. Eur J Surg Oncol. 2000; 26: 3438.
  • 20
    Zucali R, Kenda R. Small size T4 breast cancer. Natural history and prognosis. Tumori. 1981; 67: 225230.
  • 21
    Touboul E, Lefranc JP, Blondon J, et al. Primary chemotherapy and preoperative irradiation for patients with Stage II larger than 3 cm or locally advanced non-inflammatory breast cancer. Radiother Oncol. 1997; 42: 219229.
  • 22
    Hortobagyi GN, Ames FC, Buzdar AU, et al. Management of Stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer. 1988; 62: 25072516.
  • 23
    Haagensen C, Stout A. Carcinoma of the breast: criteria of inoperability. Am Surg. 1943; 118: 859866.
  • 24
    Haagensen C. Clinical classification of the stage of advancement of breast carcinoma. Diseases of the breast, 3rd ed. Philadelphia: WB Saunders Company, 1986: 851863.
  • 25
    Witherspoon L. Discussion on “Management of women who present with T4 breast cancer” by GV Poole et al. Am Surg. 2004; 70: 666667.
  • 26
    McCarty K, Nath M. Breast: lymphatic drainage. In: SternbergS, editor. Histology for pathologists, 2nd ed. Philadelphia: Lippincott-Raven, 1997: 76.
  • 27
    Tanis PJ, Nieweg OE, Valdes Olmos RA, Kroon BB. Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg. 2001; 192: 399409.
  • 28
    Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999; 353: 11191126.
  • 29
    Ramirez AJ, Westcombe AM, Burgess CC, Sutton S, Littlejohns P, Richards MA. Factors predicting delayed presentation of symptomatic breast cancer: a systematic review. Lancet. 1999; 353: 11271131.
  • 30
    Anderson WF, Chu KC, Chang S. Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities? J Clin Oncol. 2003; 21: 22542259.